A predoctoral BIODEFENSE TRAINING PROGRAM is proposed at the University of Texas Medical Branch (UTMB). The program will capitalize on UTMB's outstanding high containment facilities, including the only BSL-4 laboratory at a U.S. university, extensive, and externally funded research opportunities to study the majority of NIAID Category A-C Priority Pathogens with high experienced faculty scientists. Research opportunities include several major NIH-funded programs such as the Emerging Viral Diseases Unit, the World Reference Center for Emerging Viruses and Arboviruses, the Biodefense Proteomics Collaboratory, and many regional, multidisciplinary biodefense projects through the UTMB-led Region VI Center of Excellence in Biodefense and Emerging Infectious Diseases. The program will foster the interdisciplinary training of young biodefense scientists through: 1) role-modeling by experienced faculty mentors; 2) flexible but rigorous didactic preparation in a wide variety of biomedical disciplines, through one of five different UTMB graduate programs, but united by a required, specialized biodefense curriculum and seminar series; 3) high containment laboratory training, including opportunities for animal and vector research training at BSL-3 and BSL-4; 4) pursuit of a specific biodefense-related dissertation research project under the supervision of experienced, externally funded, highly accomplished faculty members, and; 5) development of professional and ethical behavior that will promote high quality research and effective interdisciplinary interactions. Trainees will be selected from a highly competitive applicant pool of students who have completed their required, first year core courses. The recruitment of underrepresented minority students will be enhanced by an NIH-funded partnering program involving 7 undergraduate institutions with large minority enrollments, and through UTMB's Summer Undergraduate Research Program and Undergraduate Research Symposium, both of which specifically and successfully target minority students. Junior program faculty will develop their mentoring skills and biodefense careers with guidance from an internal Executive Committee and from regular interactions with experienced co-mentors. An external advisory committee composed of outstanding, internationally recognized biodefense scientists and experienced research mentors will periodically review and guide the program through site visits.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Institutional National Research Service Award (T32)
Project #
5T32AI060549-02
Application #
6910735
Study Section
Microbiology and Infectious Diseases B Subcommittee (MID)
Program Officer
Garges, Susan
Project Start
2004-07-01
Project End
2009-06-30
Budget Start
2005-07-01
Budget End
2006-06-30
Support Year
2
Fiscal Year
2005
Total Cost
$87,155
Indirect Cost
Name
University of Texas Medical Br Galveston
Department
Pathology
Type
Schools of Medicine
DUNS #
800771149
City
Galveston
State
TX
Country
United States
Zip Code
77555
Andersson, Jourdan A; Sha, Jian; Kirtley, Michelle L et al. (2018) Combating Multidrug-Resistant Pathogens with Host-Directed Nonantibiotic Therapeutics. Antimicrob Agents Chemother 62:
Beck, Andrew S; Wood, Thomas G; Widen, Steven G et al. (2018) Analysis By Deep Sequencing of Discontinued Neurotropic Yellow Fever Vaccine Strains. Sci Rep 8:13408
Barrows, Nicholas J; Campos, Rafael K; Liao, Kuo-Chieh et al. (2018) Biochemistry and Molecular Biology of Flaviviruses. Chem Rev 118:4448-4482
Burtnick, Mary N; Shaffer, Teresa L; Ross, Brittany N et al. (2017) Development of Subunit Vaccines that Provide High Level Protection and Sterilizing Immunity Against Acute Inhalational Melioidosis. Infect Immun :
Soong, Lynn; Shelite, Thomas R; Xing, Yan et al. (2017) Type 1-skewed neuroinflammation and vascular damage associated with Orientia tsutsugamushi infection in mice. PLoS Negl Trop Dis 11:e0005765
Tao, Pan; Mahalingam, Marthandan; Zhu, Jingen et al. (2017) A Bivalent Anthrax-Plague Vaccine That Can Protect against Two Tier-1 Bioterror Pathogens, Bacillus anthracis and Yersinia pestis. Front Immunol 8:687
Manning, John T; Seregin, Alexey V; Yun, Nadezhda E et al. (2017) Absence of an N-Linked Glycosylation Motif in the Glycoprotein of the Live-Attenuated Argentine Hemorrhagic Fever Vaccine, Candid #1, Results in Its Improper Processing, and Reduced Surface Expression. Front Cell Infect Microbiol 7:20
Andersson, Jourdan A; Sha, Jian; Erova, Tatiana E et al. (2017) Identification of New Virulence Factors and Vaccine Candidates for Yersinia pestis. Front Cell Infect Microbiol 7:448
Plante, Jessica A; Torres, Maricela; Huang, Claire Y-H et al. (2016) Plasticity of a critical antigenic determinant in the West Nile virus NY99 envelope protein domain III. Virology 496:97-105
Nusbaum, Rebecca J; Calderon, Veronica E; Huante, Matthew B et al. (2016) Pulmonary Tuberculosis in Humanized Mice Infected with HIV-1. Sci Rep 6:21522

Showing the most recent 10 out of 87 publications